zika

Congress Passes Zika Funding Bill

Congress passed and President Obama signed a 10-week continuing resolution, which includes $1.1 billion for Zika virus research.
Read

ASM Acts to Counter Zika Virus Outbreak

The emerging threat of Zika virus infection.
Read

ASM Urges Action to Combat Zika Emergency

Current events linked to the Zika virus make aggressive public health actions and funding to combat this emerging infectious disease more crucial than ever.
Read
Become a member today!
JOIN ASM
Submit Abstracts for Biothreats 2017
SUBMIT
Antibacterial Development Conference
REGISTER

The American Society for Microbiology held a Congressional Briefing, "The Perpetual Challenge of Infectious Diseases: New and Emerging and Antimicrobial Resistance" on April 30, 2013.

Program:

Introduction and Overview
Gail H. Cassell, Ph.D.
Past President, American Society for Microbiology
Visiting Professor, Harvard Medical School

Infectious Diseases in the 21st Century: Challenges and Opportunities
Anthony S. Fauci, M.D.
Director, National Institute of Allergy and Infectious Diseases
National Institutes of Health

The Role of the NIH Clinical Center in Understanding Disease Pathogenesis and Drug Discovery
John I. Gallin, M.D.
Director, Clinical Center and Associate Director for Clinical Research
National Institutes of Health

Global Crisis of Drug Resistant Tuberculosis: a Case Study in the Critical Role of NIH
Gail H. Cassell, Ph.D.
Past President, American Society for Microbiology
Visiting Professor, Harvard Medical School

If you have any questions about the briefing please contact publicaffairs@asmusa.org.

TPL_asm2013_SEARCH

91639